NYSE
76.85USD
+4.11 (+5.65%)
We have scored 36 news catalysts on Inspire Medical Systems, Inc. (INSP) over the past 12 months. The biggest single-day move next to one of them came Dec 13, 2025, when INSP closed −4.9%: “INSP FRAUD UPDATE: Important Inspire Medical Systems, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before January 5”. Coverage across the window leans negative (average ticker sentiment −0.54). Most of the impact sits in forward growth expectations and earnings revision trend.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.3B
P/E
—
EPS
—
Beta
0.70
52W range
38.91-147.03
Day range
71.43–77.06
Open
72.29
Prev close
72.74
Volume
485.4K
Avg volume
932.8K
Dividend
0.00
IPO
2018-05-03
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Inspire Medical Systems, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for INSP: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
